
| Company | Ticker | Business Description | Underwriters | Offer Date |
|---|---|---|---|---|
| Azitra> | AZTR> | Phase 1-ready dermatology biotech developing engineered bacterial therapies. | ThinkEquity |
06/15/23 |
| News Results for Azitra |
|---|
| US IPO Weekly Recap: Restaurant chain CAVA finishes up 73% after a successful IPO 06/16/23 |
| Skin in the game: Dermatology biotech Azitra prices IPO at $5 midpoint 06/16/23 |